“Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab: A consensus statement of the Working Party on Haemostasis of the Swiss Society of Haematology and the Swiss Haemophilia Network” (2020) Swiss Medical Weekly, 150(5153), p. w20422. doi:10.4414/smw.2020.20422.